WHITE PLAINS, N.Y., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Iantrek, Inc., a leader in bio-interventional ophthalmic surgery (BIOS), today announced the official U.S. commercial launch of AlloFlo™ Uveo, a ...
White Plains, March 18, 2025 (GLOBE NEWSWIRE) -- Iantrek Announces Positive 2-Year Results Demonstrating Efficacy and Safety of Its Bio-Interventional Technology for Uveoscleral Outflow Enhancement in ...
New hope for millions of glaucoma patients as funding advances surgical access to the uveoscleral pathway WHITE PLAINS, N.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Iantrek, Inc., a pioneer in ...
AlloFlo™ Uveo expands interventional options for glaucoma surgeons and patients With over 100 surgeon partners and thousands of cases performed throughout the early-release program, Iantrek pioneers a ...
(MENAFN- GlobeNewsWire - Nasdaq) New hope for millions of glaucoma patients as funding advances surgical access to the uveoscleral pathway WHITE PLAINS, N.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Iantrek ...
With over 100 surgeon partners and thousands of cases performed throughout the early-release program, Iantrek pioneers a new era in minimally invasive bio-interventional ophthalmic surgery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback